Using a special eye-scan to study kidney biopsy samples
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether a noninvasive “eye-scan” during a kidney biopsy can help doctors tell the difference between acute kidney injury and chronic kidney disease. If it works, it may improve how kidney problems are diagnosed in routine practice.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 18 years
- Your kidney doctor suspects acute kidney injury and plans a kidney biopsy
- OR your kidney doctor suspects chronic kidney disease and plans a kidney biopsy
- You can have a dynamic full-field optical coherence tomography scan at the time of the biopsy (the special eye-scan)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new light-based method to check kidney function right after heart surgery or imaging tests that use contrast dye. It aims to catch kidney damage early, so doctors can treat it sooner.
This trial tests whether using a much smaller amount of contrast dye for an invasive heart scan is safer for people with acute kidney injury (AKI). It may help reduce further kidney stress while still allowing doctors to look at coronary (heart) arteries.
This study uses a special MRI scan to look at the kidneys in people with different kinds of kidney disease, including acute kidney injury, chronic kidney disease, vasculitis, and after a kidney transplant. The goal is to better understand these conditions.
This study tests if a simple blood test (cystatin) can detect kidney damage earlier in people with chronic kidney disease who receive contrast dye for imaging. It could help doctors act faster to protect kidneys.
This study is looking at how chronic kidney disease (CKD) affects the eyes, brain, and kidneys. It uses MRI scans to examine these organs, and aims to find connections that could help improve care for people with CKD.
This study tests a special eye test (fluorescein angiography) in people with diabetes and advanced kidney disease. The goal is to see how well the test works to check the health of blood vessels in the eye.
Hear when a new Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.